Psychiatry

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

A study of medical school applicants through their education showed those more expected to become a doctor by their parents are more likely to feel the strains of becoming one.

If approved, Spravato would become the first novel mechanism of action in 30 years to treat major depressive disorder.

The US Preventive Services Task Force has recommended that clinicians refer pregnant and postpartum persons who are at risk of depression for counseling services.

Physicians on the front lines of care should be empowered to consider alternative treatment options for patients in significant need.

Teenaged athletes to suffer from sports-related concussion symptoms may fare better from more active exercise, despite standard concussion treatment strategies.

A new study found that physician mothers commonly have responsibilities outside of their children and patients—and that such burdens are linked to more anxiety and burnout.

A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.

A new study found the biggest burden of benzodiazepine-related visits have come from primary care physicians, and that efforts to limit sedative prescription may have to start there.

Why certain age-related factors particularly impact the mental health of women at the age their menopause symptoms appear.

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

Differing therapies, inaccurate regimens, missed diagnoses—issues can compound quickly for patients with PD seeking care for something else.

Some of the most common symptoms of COPD drive anxiety in its patients. An England-based study sought out a cost-effective response.

A pilot study testing a multi-tasking game in children with autism and ADHD demonstrated feasibility, acceptability, and non-significant efficacy.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

Patients treated with SAGE-217 had significantly improved depression scores and were more likely to achieve remission than those receiving placebo.

The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.

Patient and caregiver assessments should be considered alongside clinician assessments during tardive dyskinesia screening procedures, as they may differ.

Prenatal exposure to the antiepileptic drug valproate is associated with increased risk for ADHD independent of its link to congenital malformations.

MD Magazine's most popular stories this year ranged from new clinical insights, to physician-submitted columns, to perspectives on burnout in the workplace.

Tardive dyskinesia made strides in 2018 with new and potential treatments as well as unearthed disease underpinnings.

A more multidisciplinary, collaborative care effort for these patients can result in more active monitoring and productive clinical care.